Reset filters
  • 4 April 2007

Tibotec licenses darunavir to Aspen in Africa

Read the article
  • 19 March 2007

Next generation NRTI, apricitabine (ATC), shows early promise

Read the article
  • 6 March 2007

CROI: Experimental 'salvage' integrase inhibitor, elvitegravir (GS-9137) appears potent at higher doses

Read the article
  • 2 March 2007

CROI: New NNRTI, TMC278, demonstrates sustained potency, better CNS and lipid profile than efavirenz, in treatment-naive

Read the article
  • 28 February 2007

CROI: Maraviroc shows potent effect in highly treatment-experienced

Read the article
  • 28 February 2007

CROI: Integrase inhibitor raltegravir (MK-0518) doubles HIV suppression in treatment-experienced patients at 16 weeks

Read the article
  • 22 February 2007

Health Canada issues warning on use of Baraclude alone in HIV/hepatitis B coinfected

Read the article
  • 20 February 2007

Merck announces plans for licensing Atripla widely in developing world

Read the article
  • 15 February 2007

Posaconazole successful in treating fluconazole- and itraconazole-resistant candidiasis

Read the article

Receive the latest HIV research and conference news

Complete this form to receive regular email bulletins including the latest HIV research and conference news from aidsmap and/or updates from Terrence Higgins Trust.

Get regular email bulletins

Please let us know how you'd like to be contacted by ticking the options below.